Vir Biotechnology

Biotechnology

Vir Biotechnology is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. The company leverages cutting-edge technologies to develop therapeutic antibodies and T-cell therapies targeting hepatitis B, influenza, COVID-19, and other diseases. Vir employs insights from natural immune responses to infectious disease.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me